Using two neuroblastoma cell lines, SK-N-AS and IMR-32, derived from patients with bone and abdominal metastases, respectively, we investigated the role of the CCT chaperonin as an enabler of a migratory phenotype in these cells. Here, FLVCR2 is linked to neuroblastoma.